IMT Outcomes in Sufferers of Severe Walking Disabilities and Intensive Care Unit Acquired Weakness - Trial NCT06210763
Access comprehensive clinical trial information for NCT06210763 through Pure Global AI's free database. This phase not specified trial is sponsored by Cairo University and is currently Recruiting. The study focuses on Intensive Care Unit Acquired Weakness. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Threshold IMT and traditional physical therapy program
Interventional
behavioral
Sponsor & Location
Cairo University
Timeline & Enrollment
N/A
Aug 02, 2023
Mar 30, 2024
Primary Outcome
Modified Functional Ambulation Category Test
Summary
Intensive care unit-acquired weakness (ICU-acquired weakness) may be caused by a variety of
 different causes. Several studies have shown that ICU-acquired weakness occurs in up to 30%
 of critically ill patients. It affects daily activities, walking, and functional performance
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06210763
Non-Device Trial